Thalidomide-NH-C6-NH2 (TFA), 250mg

(butan-2-yl)[(2,4-dichlorophenyl)methyl]amine, 95.0%, 1g

Potassium (2-cyanophenyl)trifluoroborate, 95.0%, 5g

5-Cyclopropylpyrimidin-2-amine, 97%, 1g

(S)-4-Isopropyl-2-oxazolidinone>98.0%(GC)1g

(R)-N-(2-((2-Hydroxyphenyl)amino)-3,4-dioxocyclobut-1-en-1-yl)-2-methylpropane-2-sulfinamide, 97%, 100mg

4-Pyrrolidinopyridine, 95.0%, 10g

2-Amino-1-propene-1,1,3-tricarbonitrile, 98.0%, 10g

6-(4-(1H-Pyrazolo[3,4-b]pyridin-3-yl)piperidin-1-yl)-2-chloropyrimidine-4-carboxylic acid, 25mg

1-AZASPIRO[4.5]DECAN-8-AMINE HCL, 95.0%, 50mg

2-Chloro-quinoline, 95.0%, 5g

1H-INDOLE-1-CARBOXYLIC ACID, 5-(BROMOMETHYL)-, 1,1-DIMETHYLETHYL ESTER, 95%, 1g

Phenyl N-Acetyl-alpha-D-glucosaminide>98.0%(HPLC)100mg